Whitney joined the team at the Stanford University’s Sean N. Parker Center for Asthma and Allergy Research as the lead nurse practitioner in 2013, where multi-allergen food desensitization with and without omalizumab (Xolair) was pioneered. She was the lead clinician on the first phase 2 research trials studying Xolair in conjunction with oral immunotherapy for multiple allergens simultaneously. In this role, Whitney worked with patients and colleagues to develop and optimize protocols for multi-food oral immunotherapy and co-authored trial results in addition to many other research publications. In pursuing her passion to help children overcome food allergies and create more happy childhoods, Whitney felt compelled to open the National Allergy Center and began treating patients with state of the art food allergy therapies.
Whitney has co-authored numerous research publications including Guidelines for Diagnosing Food Allergy (Pediatric Clinics of North America, December 2015), Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial (Lancet Gastroenterology and Hepatology, December 2017), Feasibility of sustained response through long-term dosing in food allergy immunotherapy (Allergy, Asthma and Clinical Immunology, December 2017), and many others.
Whitney has dual board certifications as a pediatric and family nurse practitioner and is experienced treating patients of all ages. She received a Masters in Nursing from Vanderbilt University and a Bachelors of Science in Nursing from Johns Hopkins University. Before treating patients with food allergies she worked with the Centers for Disease Control on a nationwide research tour focused on pediatric health and nutrition.